Victory Capital Management
VIVO

Victory Capital Management’s Meridian Bioscience Inc VIVO Stock Holding History

Victory Capital Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-26,441
Closed -$878K – 2747
2022
Q4 		$878K Sell
26,441
-17,526
-40% -$565K ﹤0.01% 1802
2022
Q3 		$1.39M Sell
43,967
-108,816
-71% -$3.52M ﹤0.01% 1588
2022
Q2 		$4.65M Sell
152,783
-6,243
-4% -$169K 0.01% 1265
2022
Q1 		$4.11M Buy
159,026
+4,395
+3% +$105K ﹤0.01% 1325
2021
Q4 		$3.15M Buy
154,631
+25,640
+20% +$492K ﹤0.01% 1427
2021
Q3 		$2.48M Buy
128,991
+1,949
+2% +$38.9K ﹤0.01% 1534
2021
Q2 		$2.82M Sell
127,042
-3,893
-3% -$82.6K ﹤0.01% 1532
2021
Q1 		$3.44M Buy
130,935
+81,450
+165% +$1.94M ﹤0.01% 1473
2020
Q4 		$925K Sell
49,485
-5,151
-9% -$96.2K ﹤0.01% 1820
2020
Q3 		$928K Sell
54,636
-79,116
-59% -$1.54M ﹤0.01% 1737
2020
Q2 		$3.12M Sell
133,752
-186,918
-58% -$2.71M ﹤0.01% 1296
2020
Q1 		$2.69M Buy
320,670
+151,014
+89% +$1.27M ﹤0.01% 1478
2019
Q4 		$1.66M Buy
169,656
+27,737
+20% +$260K ﹤0.01% 1578
2019
Q3 		$1.35M Buy
141,919
+81,095
+133% +$855K ﹤0.01% 1614
2019
Q2 		$723K Sell
60,824
-4,756
-7% -$57.3K ﹤0.01% 1345
2019
Q1 		$1.16M Sell
65,580
-33,054
-34% -$550K ﹤0.01% 1222
2018
Q4 		$1.71M Buy
98,634
+8,235
+9% +$140K ﹤0.01% 1073
2018
Q3 		$1.35M Buy
90,399
+35,399
+64% +$549K ﹤0.01% 1206
2018
Q2 		$875K Buy
55,000
+1,085
+2% +$16.2K ﹤0.01% 1284
2018
Q1 		$766K Buy
53,915
+21,175
+65% +$313K ﹤0.01% 1291
2017
Q4 		$458K Buy
32,740
+1,987
+6% +$29.1K ﹤0.01% 1336
2017
Q3 		$440K Sell
30,753
-2,967
-9% -$42.4K ﹤0.01% 1342
2017
Q2 		$531K Buy
33,720
+2,520
+8% +$36.3K ﹤0.01% 1301
2017
Q1 		$431K Buy
31,200
+5,844
+23% +$81.7K ﹤0.01% 1337
2016
Q4 		$449K Sell
25,356
-1,732
-6% -$30.4K ﹤0.01% 1285
2016
Q3 		$523K Buy
27,088
+4,294
+19% +$84K ﹤0.01% 1239
2016
Q2 		$444K Buy
22,794
+3,409
+18% +$66.9K ﹤0.01% 1069
2016
Q1 		$400K Sell
19,385
-4,266
-18% -$84.1K ﹤0.01% 1082
2015
Q4 		$485K Buy
23,651
+8,450
+56% +$162K ﹤0.01% 1041
2015
Q3 		$260K Buy
15,201
+3,734
+33% +$68.2K ﹤0.01% 1084
2015
Q2 		$213K Buy
+11,467
New +$213K ﹤0.01% 1103

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Victory Capital Management's VIVO Position: Q1 2023 in Review

Victory Capital Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 26,441 shares — an estimated $878K sold.

Victory Capital Management first reported a position in VIVO in Q2 2015 and held it in 31 quarters. The position peaked at $4.65M in Q2 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Victory Capital Management reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Victory Capital Management sold 26,441 Meridian Bioscience Inc shares in Q1 2023, an estimated $878K.
  • Victory Capital Management first reported a position in Meridian Bioscience Inc in Q2 2015 and held it in 31 quarters.
  • Victory Capital Management's Meridian Bioscience Inc position peaked at $4.65M in Q2 2022.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Victory Capital Management's 13F filing for Q1 2023, filed 2 May 2023.